Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

By Luo Hong  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 937-945

Springer Publishing Company

Access to resources Recommend Favorite

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 91-98

Spandidos Publications

Access to resources Recommend Favorite

Activity of docetaxel in paclitaxel-resistant ovarian cancer cells

By Sato Shinya   Kigawa Junzo   Kanamori Yasunobu   Itamochi Hiroaki   Oishi Tetsuro   Shimada Muneaki   Iba Takahiro   Naniwa Jun   Uegaki Kazunori   Terakawa Naoki  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 247-252

Springer Publishing Company

Access to resources Recommend Favorite

Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

By Yang Lingyun   Li Ningwei   Wang Hongjing   Jia Xibiao   Wang Xue   Luo Juan  

Oncology Reports, Vol. 28, Iss. 2, 2012-08 ,pp. : 592-600

Spandidos Publications

Access to resources Recommend Favorite